Omega Healthcare Investors raises 2026 AFFO guidance after strong Q3 results

Omega Healthcare Investors reported third‑quarter 2026 adjusted FFO of $0.82 per share and revenue of about $340.6 million, up 9% year‑over‑year. Net income was roughly $87 million, and occupancy improved to 82.7%. The company lifted its full‑year 2026 Adjusted FFO guidance to $3.28–$3.30 per diluted share.

The higher guidance signals stronger cash‑flow generation, which may support a higher valuation for the REIT (the company said the raise reflects continued investment activity). Analysts will likely adjust their models to the new $3.28–$3.30 AFFO range.

Sources